1975
DOI: 10.1002/1097-0142(197511)36:5<1646::aid-cncr2820360518>3.0.co;2-a
|View full text |Cite
|
Sign up to set email alerts
|

Antibody as carrier of131I in cancer diagnosis and treatment

Abstract: Cell-surface localizing heterologous antibodies against mouse EL4 lymphoma, Ehrlich ascites carcinoma, and several human malignant tumors could be bound to varying amounts of 131I without interfering with the reactivity of these antibodies with their respective tumor cells. Exposure of the mouse tumor cells to radio-iodinated antitumor antibodies in vitro, or the injection of radio-iodinated antitumor antibodies into mice preinoculated with tumor cells resulted in either partial or complete tumor inhibition de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1977
1977
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…The specificity of anti-HMEC will allow for the identification of normal and neoplastic breast epithelial cells in mixed primary cultures and in isolated metastases with unknown carcinoma of origin (33), and provide a means for the purification of this cell type from mixed cell suspensions. Also, anti-HMEC could be used as a vector to carry cytotoxic substances to neoplastic breast tissue (33).…”
Section: Resultsmentioning
confidence: 99%
“…The specificity of anti-HMEC will allow for the identification of normal and neoplastic breast epithelial cells in mixed primary cultures and in isolated metastases with unknown carcinoma of origin (33), and provide a means for the purification of this cell type from mixed cell suspensions. Also, anti-HMEC could be used as a vector to carry cytotoxic substances to neoplastic breast tissue (33).…”
Section: Resultsmentioning
confidence: 99%
“…Several approaches were used as long ago as some 50 years to evaluate the potential therapeutic effect in different xenograft models [2,3]. Promising results were shown in different tumour cell lines in vitro and in vivo [4][5][6][7]. One of the first human applications was reported in the late 1960s [8].…”
mentioning
confidence: 99%
“…to sample processing have been described in the literature including: exhaustively perfusing the experimental animals with saline to remove all blood (Koji et al 1980); mincing and homogenizing the tissue and washing repeatedly, blending and weighing the wet specimen (Bernhard et al 1983), washing tissues several times in phosphate-buffered saline "to get rid of as much blood as possible" (Ghose et al 1975); lightly blotting surface blood from the target tissues, weighing and counting them with contained blood present (Wahl and Parker 1983c); carefully removing the tissue, weighing and counting (Hoffer et al 1973); and not clearly specified which we assume to mean simple excision and counting (Primus et al 1973).…”
mentioning
confidence: 99%